A Phase II Trial of Cabozantinib With Patients With Refractory GCTs

Clinical trial NCT04876456 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04876456
Sponsor: Jennifer King
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Germ Cell Tumor Seminoma Non-seminomatous Germ Cell Tumor Ovarian Germ Cell Tumor

Start date: 2021-06-10
Primary completion: 2027-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.